samedan logo
 
 
spacer
home > ebr > summer 2002 > the pivotal role of it systems in drug delivery and innovation
PUBLICATIONS
European BioPharmaceutical Review

The Pivotal Role of IT Systems in Drug Delivery and Innovation

Almost every article about the fate of modern drug discovery or information technology in the life science sector begins by describing the challenges resulting from the enormous data deluge. This article is no exception. The human and mouse genomes have been drafted, the rat genome is awaiting its completion in 2003, high throughput technologies in genomics, screening and chemistry have been established, creating massive amounts of data. There are estimates that even the terabyte scale is already off by an order of magnitude, so when people start talking about petabytes of data, science needs to make sense of it.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Jцrg Sprengel, Executive Project Director i-biology® at LION bioscience AG

Dr Jцrg Sprengel has been with LION bioscience AG since April 2000 and is now Executive Project Director i-biology®. Previously, he spent five years in Belgium at Janssen Research Foundation (JRF), a Johnson & Johnson Company.
In 1997, Jцrg was Head of the Bioinformatic Group at JRF and was honoured for his contribution to the pharmaceutical industry with the Johnson & Johnson Innovation Award. After studying molecular biology, physics and plant physiology, he received a PhD for his work on the genome analysis of human adenovirus type 12 from the University of Cologne.

spacer
Dr Jцrg Sprengel
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

EuroBiopartnering 2008

7-9 October 2008, Paris, France

EuroBiOpartnering 2008 gives you the unique opportunity to meet the relevant decision makers and opinion leaders from the international biotech community and offers you 3 days of partnering opportunities including one-to-one meetings, company presentations and further networking activities…
More info >>

 
News and Press Releases

Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials

HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement